drugset / Trial / NCT05668754
Study of SDX in Patients With Idiopathic Hypersomnia (IH)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study of the safety, efficacy and pharmacokinetics (PK) of Serdexmethylphenidate (SDX) compared to placebo in subjects with Idiopathic Hypersomnia (IH).
Timeline
- Start
- 2022-12-28
- Primary completion
- 2024-02-28
- Completion
- 2024-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Serdexmethylphenidate | Small molecule | 80 mg | Oral |
| Subject | Serdexmethylphenidate | Small molecule | 160 mg | Oral |
| Subject | Serdexmethylphenidate | Small molecule | 240 mg | Oral |
| Subject | Serdexmethylphenidate | Small molecule | 320 mg | Oral |